Cardlytics, Inc. (CDLX)
| Market Cap | 8.18M -89.9% |
| Revenue (ttm) | 175.92M -25.3% |
| Net Income | -36.55M |
| EPS | -6.47 |
| Shares Out | 6.10M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,520 |
| Open | 1.420 |
| Previous Close | 1.430 |
| Day's Range | 1.330 - 1.420 |
| 52-Week Range | 1.330 - 15.550 |
| Beta | 0.79 |
| Analysts | Hold |
| Price Target | 4.43 (+230.22%) |
| Earnings Date | Nov 5, 2026 |
About CDLX
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing,... [Read more]
Financial Performance
In 2025, Cardlytics's revenue was $233.27 million, a decrease of -16.18% compared to the previous year's $278.30 million. Losses were -$103.49 million, -45.33% less than in 2024.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for CDLX stock is "Hold." The 12-month stock price target is $4.43, which is an increase of 230.22% from the latest price.
News
Cardlytics price target lowered to $1.70 from $4 at BofA
BofA lowered the firm’s price target on Cardlytics (CDLX) to $1.70 from $4 and keeps an Underperform rating on the shares. The company’s Q3 came in below guidance on the…
Cardlytics price target lowered to $4 from $6 at Craig-Hallum
Craig-Hallum analyst Jason Kreyer lowered the firm’s price target on Cardlytics (CDLX) to $4 from $6 and keeps a Hold rating on the shares after a mixed Q3 as revenue…
Cardlytics price target lowered to $2 from $4 at Lake Street
Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $2 from $4 and keeps a Hold rating on the shares after Q3 results fell short of expectations. Published…
Cardlytics Earnings Call Transcript: Q3 2026
Q3 results fell short amid a one-time U.K. bank disruption and cautious advertiser budgets, while new advertiser growth and CRP partnerships expanded reach. Q4 guidance calls for 10%–20% sequential billings growth.
Cardlytics Earnings release: Q3 2026
Cardlytics released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Cardlytics Quarterly report: Q3 2026
Cardlytics has published its Q3 2026 quarterly earnings report on November 5, 2026.
Cardlytics reports Q3 EPS ($1.26), consensus ($2.02)
Reports Q3 revenue $32.9M, consensus $37.07M. “Our third quarter results came in below expectations,” said Amit Gupta, CEO of Cardlytics (CDLX). “However, we remain encouraged by the progress towards ...
Cardlytics sees Q4 revenue $35M-$39M, consensus $41.25M
Sees Q4 adjusted EBITDA ($1M)-$2M
Cardlytics Reports Third Quarter 2026 Financial Results and Provides Fourth Quarter Outlook
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the third quarter ended September 30, 2026. "Our third quarter result...
Cardlytics to Report Third Quarter 2026 Results on November 5
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the third quarter that ended September 30, 2026 will be released on November 5, 2026, after mar...
Cardlytics enters partnership with Rove
Cardlytics (CDLX) announced a new partnership with Rove extending the Cardlytics Rewards Platform and further diversifying Cardlytics’ supply footprint. The partnership gives Rove members access to Ca...
Cardlytics and Rove Team Up to Help Travelers Earn Their Next Trip Faster
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced a new partnership with Rove, the first universal airline mile program built for Gen Z and Millennials, extending the Cardlytics...
Cardlytics price target lowered to $4 from $10 at Lake Street
Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $4 from $10 and keeps a Hold rating on the shares. While “we are not there yet,” Q2 signs…
Cardlytics Earnings Call Transcript: Q2 2026
Q2 2026 saw progress on strategic priorities, with advertiser growth, improved churn, and stabilized supply. Revenue and billings declined year-over-year due to prior bank partner changes, but U.K. growth and AI-driven efficiencies stood out. Guidance for Q3 reflects stable performance and continued focus on free cash flow.
Cardlytics Earnings release: Q2 2026
Cardlytics released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Cardlytics Quarterly report: Q2 2026
Cardlytics has published its Q2 2026 quarterly earnings report on August 5, 2026.
Cardlytics reports Q2 EPS (81c), consensus ($1.35)
Reports Q2 revenue $36.88M, consensus $37M. “The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improvin...
Cardlytics sees Q3 revenue $34M-$39M, consensus $38.59M
16:05 EDT Cardlytics (CDLX) sees Q3 revenue $34M-$39M, consensus $38.59M
Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows tha...
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Le...
Cardlytics announces inducement grant under Nasdaq listing rule
Cardlytics (CDLX) announced that the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restr...
Cardlytics appoints Cheng as Chief Legal Officer
Cardlytics (CDLX) announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organiz...
Cardlytics Appoints Chris Cheng as Chief Legal Officer
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and ov...
Cardlytics to Report Second Quarter 2026 Results on August 5
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close....
Cardlytics trading halted, news pending
19:50 EDT Cardlytics (CDLX) trading halted, news pending